• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

婴儿特发性肌病性肉碱缺乏症:左旋肉碱治疗

Infantile idiopathic myopathic carnitine deficiency: treatment with L-carnitine.

作者信息

Shapira Y, Glick B, Harel S, Vattin J J, Gutman A

机构信息

Pediatric Neurology Unit, Hadassah University Hospital, Mt. Scopus Jerusalem, Israel.

出版信息

Pediatr Neurol. 1993 Jan-Feb;9(1):35-8. doi: 10.1016/0887-8994(93)90007-y.

DOI:10.1016/0887-8994(93)90007-y
PMID:8452598
Abstract

A series of 9 infants, ranging in age from 3 months to 5 years (average: 2 years), suffered from idiopathic myopathic carnitine deficiency presenting as hypotonia and motor delay. Secondary carnitine deficiency was eliminated by appropriate tests. Muscle carnitine concentration ranged from 2.3-7.1 nmol/mg non-collagen protein (NCP; average: 4.87 nmol/mg NCP; normal: 22 +/- 6 nmol/mg NCP). Lipid accumulation in muscle was observed in 2 of 8 patients. Therapy with L-carnitine (100 mg/kg/day in most patients) was given with clinical and laboratory follow-up 6 months later. In 7 of 9 patients, muscle tone and motor function improved. Muscle carnitine concentration increased to a range of 2.7-23.4 nmol/mg (average: 12.27 nmol/mg). In some patients the muscle carnitine content multiplied by a factor of 3-4, but carnitine concentration reached the normal range in only 2 patients. Most infants with idiopathic carnitine deficiency did benefit from 6 months of therapy; however, in order to achieve full recovery the duration of therapy should probably continue for longer periods, with a dose of not less than 100 mg/kg/day.

摘要

一组9名年龄在3个月至5岁(平均2岁)的婴儿患有特发性肌病性肉碱缺乏症,表现为肌张力减退和运动发育迟缓。通过适当的检查排除了继发性肉碱缺乏症。肌肉肉碱浓度范围为2.3 - 7.1纳摩尔/毫克非胶原蛋白(NCP;平均:4.87纳摩尔/毫克NCP;正常:22±6纳摩尔/毫克NCP)。8名患者中有2名观察到肌肉脂质蓄积。给予L-肉碱治疗(大多数患者为100毫克/千克/天),6个月后进行临床和实验室随访。9名患者中有7名肌张力和运动功能有所改善。肌肉肉碱浓度增加到2.7 - 23.4纳摩尔/毫克(平均:12.27纳摩尔/毫克)。在一些患者中,肌肉肉碱含量增加了3 - 4倍,但只有2名患者的肉碱浓度达到正常范围。大多数特发性肉碱缺乏症婴儿确实从6个月的治疗中受益;然而,为了实现完全康复,治疗时间可能需要持续更长,剂量不少于100毫克/千克/天。

相似文献

1
Infantile idiopathic myopathic carnitine deficiency: treatment with L-carnitine.婴儿特发性肌病性肉碱缺乏症:左旋肉碱治疗
Pediatr Neurol. 1993 Jan-Feb;9(1):35-8. doi: 10.1016/0887-8994(93)90007-y.
2
Carnitine deficiency of skeletal muscle: report of a treated case.骨骼肌肉碱缺乏症:一例治疗病例报告。
Neurology. 1976 Jul;26(7):633-7. doi: 10.1212/wnl.26.7.633.
3
Nearly fatal muscle carnitine deficiency with full recovery after replacement therapy.近乎致命的肌肉肉碱缺乏症经替代疗法后完全康复。
Neurology. 1983 Dec;33(12):1629-31. doi: 10.1212/wnl.33.12.1629.
4
Successful carnitine treatment in a non-carnitine-deficient lipid storage myopathy.非肉碱缺乏型脂质贮积性肌病中肉碱治疗成功的案例
Eur J Pediatr. 1980 Dec;135(2):205-9. doi: 10.1007/BF00441643.
5
Dominantly inherited megalencephaly, muscle weakness, and myoliposis: a carnitine-deficient myopathy within the spectrum of the Ruvalcaba-Myhre-Smith syndrome.
J Pediatr. 1993 Jul;123(1):70-5. doi: 10.1016/s0022-3476(05)81539-2.
6
Intracellular free [Ca2+] in human skeletal muscle with myopathic carnitine deficiency.患有肌病性肉碱缺乏症的人类骨骼肌中的细胞内游离[Ca2+]
Gen Physiol Biophys. 1989 Apr;8(2):91-8.
7
Successful carnitine treatment in two siblings having lipid storage myopathy with hypertrophic cardiomyopathy.对两名患有脂质贮积性肌病合并肥厚型心肌病的同胞进行肉碱治疗取得成功。
Neuropediatrics. 1985 Feb;16(1):6-12. doi: 10.1055/s-2008-1052536.
8
Primary carnitine deficiency in a male adult.一名成年男性的原发性肉碱缺乏症
J Med. 2002;33(1-4):105-10.
9
A case history of myopathic carnitine deficiency benefited by glucocorticoids and L-carnitine supplementation.一例通过补充糖皮质激素和左旋肉碱受益的肌病性肉碱缺乏症病史。
Drug Nutr Interact. 1985;3(4):191-6.
10
Muscle carnitine deficiency: adult onset lipid storage myopathy with sensory neuropathy.肌肉肉碱缺乏症:成人发病脂质贮积性肌病伴感觉性神经病。
Neurol Sci. 2010 Feb;31(1):61-4. doi: 10.1007/s10072-009-0128-5. Epub 2009 Sep 19.

引用本文的文献

1
The clinical, pathological, and genetic characteristics of lipid storage myopathy in northern China.中国北方脂质贮积肌病的临床、病理和遗传学特征。
Turk J Med Sci. 2022 Aug;52(4):1256-1265. doi: 10.55730/1300-0144.5431. Epub 2022 Aug 10.
2
The skeletal muscle phenotype of children with Neurofibromatosis Type 1 - A clinical perspective.神经纤维瘤病 1 型患儿的骨骼肌表型——临床视角。
J Musculoskelet Neuronal Interact. 2022 Mar 1;22(1):70-78.
3
Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1).
评估改良饮食和膳食补充疗法在减少肌肉脂质积累和改善 1 型神经纤维瘤病(NF1)肌肉功能中的作用。
PLoS One. 2020 Aug 10;15(8):e0237097. doi: 10.1371/journal.pone.0237097. eCollection 2020.
4
Impaired Exercise Performance and Skeletal Muscle Mitochondrial Function in Rats with Secondary Carnitine Deficiency.继发性肉碱缺乏大鼠的运动能力受损及骨骼肌线粒体功能障碍
Front Physiol. 2016 Aug 10;7:345. doi: 10.3389/fphys.2016.00345. eCollection 2016.
5
Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.肉碱及酰基肉碱:药代动力学、药理学和临床方面。
Clin Pharmacokinet. 2012 Sep 1;51(9):553-72. doi: 10.1007/BF03261931.